Analytical Data
-
Gene name
C1QDC1
- Application
-
Alternative Names
C1q domain-containing Protein 1; C1QDC1; CAPR2_HUMAN; Caprin family member 2; Caprin-2; caprin2; Cytoplasmic activation/proliferation-associated Protein 2; EEG 1; EEG1; Gastric cancer multidrug resistance-associated Protein; KIAA1873; Protein EEG-1; RNA granule Protein 140; RNG140
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6IMN6
-
Expression Region
1-158aa
-
AA Sequence
MTPVDVPVTNPAATILPVHVYPLPQQMRVAFSAARTSNLAPGTLDQPIVFDLLLNNLGETFDLQLGRFNCPVNGTYVFIFHMLKLAVNVPLYVNLMKNEEVLVSAYANDGAPDHETASNHAILQLFQGDQIWLRLHRGAIYGSSWKYSTFSGYLLYQD
-
Molecular Weight
43.12 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1QDC1, or Complement Component 1 Q-Related Protein 1, is a member of the complement system, which plays a crucial role in immune response and inflammation. Research into C1QDC1 has gained attention due to its involvement in various biological processes, including innate immunity, cellular signaling, and apoptosis. Studies have shown that C1QDC1 is expressed in various tissues and can influence the activity of immune cells, suggesting its potential as a biomarker for autoimmune diseases and cancer. Additionally, its role in modulating the complement pathway highlights its significance in inflammatory diseases. Investigating the recombinant expression of C1QDC1 allows for a better understanding of its functions and mechanisms, paving the way for novel therapeutic strategies that could target C1QDC1 in treating immune-related conditions. The ability to produce recombinant C1QDC1 facilitates detailed structural and functional analyses, fostering advancements in immunology and the development of targeted therapies. Overall, the exploration of C1QDC1's properties holds promise for enhancing our understanding of the immune system and addressing various pathological conditions.
